Topotesin (** - Hycamtin (brand name) - Topotecan (generic) **)

Other Medications

1 Clinical Trials

Description

Topotecan (brand name Hycamtin) is a chemotherapy drug used to treat certain types of cancer. In the context of colorectal cancer, it has been studied in clinical trials, often in combination with other chemotherapy agents. One notable study (NCT00316745) investigated its use in a specific sequence (IRIS followed by mFOLFOX6, or the reverse) as a first-line treatment for advanced colorectal cancer that had not been previously treated with chemotherapy. The goal was to compare the effectiveness and side effects of different treatment schedules involving topotecan and other standard chemotherapy drugs.

Mechanism of Action

Topotecan belongs to a class of chemotherapy drugs called topoisomerase inhibitors. It works by interfering with the function of topoisomerase I, an enzyme involved in DNA replication and repair. By inhibiting this enzyme, topotecan causes DNA damage, which can lead to the death of rapidly dividing cancer cells.

Side Effects

Common side effects of topotecan can include nausea Vomiting Diarrhea Fatigue Low blood counts (like anemia Neutropenia Thrombocytopenia) Hair loss And mouth sores. More serious side effects can occur Such as severe low blood counts Allergic reactions And kidney problems. The specific side effects experienced can vary depending on the dose Schedule And individual patient factors. Patients receiving topotecan should be closely monitored for side effects by their healthcare team.

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT00316745 Phase 3
Suspended
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Japan

Quick Info

Brand Name** - Hycamtin (brand name) - Topotecan (generic) **
CategoryOther Medications
Clinical Trials1
View Clinical Trials Back to Drug Glossary

Related Medications

Uracil
Other Medications
771 trials
Leucovorin
Other Medications
631 trials
Trifluridine
Other Medications
45 trials
Paclitaxel
Other Medications
43 trials
Cyclophosphamid
Other Medications
40 trials
Cyclophosphamide
Other Medications
39 trials

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.